Preclinical safety and efficacy evaluation of the Pipeline Vantage Embolization Device with Shield Technology

BACKGROUND: The Pipeline Vantage Embolization Device with Shield Technology is a next generation flow diverter developed to improve aneurysm occlusion and implant endothelialization in addition to lowering thrombogenicity. We report here the in vivo biocompatibility and in vitro hemocompatibility pe...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:J Neurointerv Surg
Huvudupphovsmän: Starke, Robert M, Thompson, John, Pagani, Ariana, Choubey, Animesh, Wainwright, John M, Wolf, Michael F, Jahanbekam, Reza, Girdhar, Gaurav
Materialtyp: Artigo
Språk:Inglês
Publicerad: BMJ Publishing Group 2020
Ämnen:
New Devices and Techniques
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7509525/
https://ncbi.nlm.nih.gov/pubmed/32487767
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/neurintsurg-2020-016043
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk